nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ORM1—saliva—periodontitis	0.0285	0.104	CbGeAlD
Gefitinib—SBK1—trigeminal ganglion—periodontitis	0.0267	0.0976	CbGeAlD
Gefitinib—ERBB3—mouth—periodontitis	0.0193	0.0704	CbGeAlD
Gefitinib—CSNK1E—trigeminal ganglion—periodontitis	0.0147	0.0539	CbGeAlD
Gefitinib—IRAK4—trigeminal ganglion—periodontitis	0.0145	0.0531	CbGeAlD
Gefitinib—CSNK1E—parotid gland—periodontitis	0.0139	0.0508	CbGeAlD
Gefitinib—IRAK4—parotid gland—periodontitis	0.0137	0.05	CbGeAlD
Gefitinib—MKNK2—trigeminal ganglion—periodontitis	0.0135	0.0495	CbGeAlD
Gefitinib—MKNK1—trigeminal ganglion—periodontitis	0.0133	0.0488	CbGeAlD
Gefitinib—MKNK2—parotid gland—periodontitis	0.0127	0.0466	CbGeAlD
Gefitinib—ERBB3—connective tissue—periodontitis	0.0118	0.0432	CbGeAlD
Gefitinib—MKNK2—connective tissue—periodontitis	0.0112	0.041	CbGeAlD
Gefitinib—ERBB3—epithelium—periodontitis	0.0112	0.041	CbGeAlD
Gefitinib—STK10—trigeminal ganglion—periodontitis	0.011	0.0402	CbGeAlD
Gefitinib—MKNK2—epithelium—periodontitis	0.0107	0.039	CbGeAlD
Gefitinib—MAP2K5—trigeminal ganglion—periodontitis	0.00982	0.0359	CbGeAlD
Gefitinib—MAP2K5—parotid gland—periodontitis	0.00926	0.0339	CbGeAlD
Gefitinib—CYP1A1—mouth—periodontitis	0.00614	0.0225	CbGeAlD
Gefitinib—ABCG2—trigeminal ganglion—periodontitis	0.00478	0.0175	CbGeAlD
Gefitinib—ABCG2—parotid gland—periodontitis	0.0045	0.0165	CbGeAlD
Gefitinib—CYP1A1—parotid gland—periodontitis	0.00428	0.0156	CbGeAlD
Gefitinib—CYP1A1—epithelium—periodontitis	0.00357	0.0131	CbGeAlD
Gefitinib—ABCB1—trigeminal ganglion—periodontitis	0.00235	0.00861	CbGeAlD
Gefitinib—ABCB1—epithelium—periodontitis	0.00186	0.00679	CbGeAlD
Gefitinib—IRAK4—Immune System—CRP—periodontitis	0.000255	0.000351	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—FGF2—periodontitis	0.000253	0.000348	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TGFB1—periodontitis	0.000253	0.000348	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—IL6—periodontitis	0.000252	0.000347	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—VCAM1—periodontitis	0.000252	0.000346	CbGpPWpGaD
Gefitinib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—periodontitis	0.000251	0.000345	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—FGF2—periodontitis	0.000249	0.000343	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD79A—periodontitis	0.000247	0.00034	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—TLR4—periodontitis	0.000244	0.000336	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL3—periodontitis	0.000244	0.000335	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1A—periodontitis	0.000243	0.000334	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SLC52A3—periodontitis	0.000243	0.000334	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL18—periodontitis	0.000243	0.000334	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—MMP2—periodontitis	0.000241	0.000332	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD14—periodontitis	0.000237	0.000326	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TNF—periodontitis	0.000236	0.000325	CbGpPWpGaD
Gefitinib—MKNK1—Disease—FGF2—periodontitis	0.000235	0.000324	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCR2—periodontitis	0.000235	0.000323	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NTRK1—periodontitis	0.000235	0.000323	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—TGFB1—periodontitis	0.000233	0.000321	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—AGER—periodontitis	0.000233	0.000321	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—IL6—periodontitis	0.000232	0.000319	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—IL6—periodontitis	0.000232	0.000319	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—GGT1—periodontitis	0.000229	0.000315	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—VCAM1—periodontitis	0.000228	0.000314	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000228	0.000314	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—TNF—periodontitis	0.000228	0.000314	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCR2—periodontitis	0.000227	0.000313	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—PPARA—periodontitis	0.000227	0.000312	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ADRB1—periodontitis	0.000226	0.000312	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—IL6—periodontitis	0.000224	0.000309	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—NOS2—periodontitis	0.000224	0.000309	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—IL6—periodontitis	0.000223	0.000307	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—AGER—periodontitis	0.000223	0.000306	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC52A3—periodontitis	0.000221	0.000305	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCR2—periodontitis	0.000219	0.000302	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—IL6—periodontitis	0.000219	0.000301	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ADRB1—periodontitis	0.000218	0.0003	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP3—periodontitis	0.000218	0.0003	CbGpPWpGaD
Gefitinib—EGFR—Immune System—FCGR2A—periodontitis	0.000218	0.0003	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—TNF—periodontitis	0.000218	0.0003	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—FGF2—periodontitis	0.000216	0.000297	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000213	0.000293	CbGpPWpGaD
Gefitinib—MKNK1—Disease—PTGS2—periodontitis	0.000212	0.000292	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ACP5—periodontitis	0.000211	0.000291	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—IL6—periodontitis	0.00021	0.000288	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCR2—periodontitis	0.000207	0.000284	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MET—periodontitis	0.000206	0.000284	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—IL6—periodontitis	0.000206	0.000284	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—ADRB1—periodontitis	0.000206	0.000283	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CRP—periodontitis	0.000203	0.00028	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1A—periodontitis	0.000202	0.000278	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TIMP1—periodontitis	0.000202	0.000278	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL18—periodontitis	0.000202	0.000278	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC52A3—periodontitis	0.000199	0.000274	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—IL6—periodontitis	0.000197	0.000271	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—IL6—periodontitis	0.000196	0.00027	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—IL6—periodontitis	0.000195	0.000268	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—TLR4—periodontitis	0.000195	0.000268	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CRP—periodontitis	0.000194	0.000267	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—IL6—periodontitis	0.000194	0.000267	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC52A3—periodontitis	0.000194	0.000267	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—AGER—periodontitis	0.000194	0.000267	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—FGF2—periodontitis	0.000189	0.000261	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—IL6—periodontitis	0.000189	0.00026	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CCR2—periodontitis	0.000189	0.00026	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1RN—periodontitis	0.000188	0.000259	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—TLR4—periodontitis	0.000186	0.000256	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—IL6—periodontitis	0.000186	0.000256	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NTRK1—periodontitis	0.000185	0.000255	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—IL6—periodontitis	0.000184	0.000253	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—FGF2—periodontitis	0.000183	0.000252	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC52A3—periodontitis	0.000183	0.000252	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—IL6—periodontitis	0.000183	0.000251	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	0.000183	0.000251	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—IL6—periodontitis	0.000183	0.000251	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCR2—periodontitis	0.000183	0.000251	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CCL2—periodontitis	0.000182	0.000251	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ADRB1—periodontitis	0.000182	0.00025	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC52A3—periodontitis	0.000181	0.000249	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—MMP9—periodontitis	0.000181	0.000249	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—IL6—periodontitis	0.000181	0.000249	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—PPARA—periodontitis	0.00018	0.000247	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—IL6—periodontitis	0.000179	0.000247	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000179	0.000246	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NTRK1—periodontitis	0.000179	0.000246	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—IL6—periodontitis	0.000179	0.000246	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IFNG—periodontitis	0.000178	0.000245	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000176	0.000243	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—VIP—periodontitis	0.000176	0.000242	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR2—periodontitis	0.000175	0.000242	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP3—periodontitis	0.000172	0.000237	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP2—periodontitis	0.000172	0.000237	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NOS2—periodontitis	0.000171	0.000235	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CRP—periodontitis	0.000169	0.000233	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP3—periodontitis	0.000166	0.000229	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PTGS2—periodontitis	0.000165	0.000227	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD79A—periodontitis	0.000165	0.000227	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—FGF2—periodontitis	0.000165	0.000227	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—FGF2—periodontitis	0.000163	0.000225	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000163	0.000224	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TLR4—periodontitis	0.000162	0.000223	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	0.000162	0.000223	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—IL6—periodontitis	0.00016	0.00022	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000159	0.000219	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL1B—periodontitis	0.000159	0.000219	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD14—periodontitis	0.000158	0.000218	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCR2—periodontitis	0.000157	0.000216	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—MMP3—periodontitis	0.000157	0.000215	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000156	0.000215	CbGpPWpGaD
Gefitinib—MKNK1—Disease—TGFB1—periodontitis	0.000153	0.000211	CbGpPWpGaD
Gefitinib—EGFR—Immune System—VCAM1—periodontitis	0.000153	0.00021	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ACP5—periodontitis	0.000152	0.000209	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—FGF2—periodontitis	0.000151	0.000208	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NTRK1—periodontitis	0.000149	0.000205	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000146	0.000201	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—FGF2—periodontitis	0.000144	0.000199	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CXCL8—periodontitis	0.000144	0.000198	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ACP5—periodontitis	0.000143	0.000197	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IFNG—periodontitis	0.000142	0.000196	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CCL2—periodontitis	0.000142	0.000195	CbGpPWpGaD
Gefitinib—ERBB3—Disease—FGF2—periodontitis	0.000139	0.000192	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—FGF2—periodontitis	0.000139	0.000191	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP3—periodontitis	0.000138	0.00019	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1A—periodontitis	0.000135	0.000186	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL18—periodontitis	0.000135	0.000186	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000133	0.000184	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ACP5—periodontitis	0.00013	0.00018	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MMP9—periodontitis	0.00013	0.000179	CbGpPWpGaD
Gefitinib—EGFR—Immune System—AGER—periodontitis	0.00013	0.000178	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP9—periodontitis	0.000129	0.000178	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—FGF2—periodontitis	0.000128	0.000176	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000128	0.000176	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—IL6—periodontitis	0.000127	0.000175	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1B—periodontitis	0.000127	0.000174	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTGS2—periodontitis	0.000126	0.000173	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—FGF2—periodontitis	0.000126	0.000173	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—MMP1—periodontitis	0.000126	0.000173	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—IL6—periodontitis	0.000124	0.000171	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR2—periodontitis	0.000122	0.000168	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADRB1—periodontitis	0.000122	0.000167	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC52A3—periodontitis	0.00012	0.000164	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TGFB1—periodontitis	0.000119	0.000164	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IFNG—periodontitis	0.000118	0.000163	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GGT1—periodontitis	0.000118	0.000162	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ACP5—periodontitis	0.000117	0.000161	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—TGFB1—periodontitis	0.000117	0.000161	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000117	0.000161	CbGpPWpGaD
Gefitinib—MKNK1—Disease—IL6—periodontitis	0.000116	0.000159	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000115	0.000158	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ACP5—periodontitis	0.000114	0.000157	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS2—periodontitis	0.000113	0.000156	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CRP—periodontitis	0.000113	0.000156	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—periodontitis	0.000113	0.000155	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CXCL8—periodontitis	0.000112	0.000154	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL2—periodontitis	0.000112	0.000154	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—PPARA—periodontitis	0.000111	0.000153	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR4—periodontitis	0.000108	0.000149	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL2—periodontitis	0.000108	0.000149	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ACP5—periodontitis	0.000108	0.000148	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFB1—periodontitis	0.000107	0.000148	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000107	0.000148	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ACP5—periodontitis	0.000107	0.000147	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TGFB1—periodontitis	0.000107	0.000147	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—periodontitis	0.000106	0.000146	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—periodontitis	0.000106	0.000145	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000105	0.000144	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL2—periodontitis	0.000102	0.00014	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP9—periodontitis	0.000101	0.00014	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—FGF2—periodontitis	0.000101	0.000139	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—periodontitis	9.95e-05	0.000137	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NTRK1—periodontitis	9.95e-05	0.000137	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—FGF2—periodontitis	9.76e-05	0.000134	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	9.72e-05	0.000134	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	9.55e-05	0.000131	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS2—periodontitis	9.52e-05	0.000131	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—periodontitis	9.31e-05	0.000128	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP3—periodontitis	9.25e-05	0.000127	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFB1—periodontitis	9.09e-05	0.000125	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL2—periodontitis	8.99e-05	0.000124	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—periodontitis	8.99e-05	0.000124	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCL8—periodontitis	8.86e-05	0.000122	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCL8—periodontitis	8.54e-05	0.000118	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GGT1—periodontitis	8.43e-05	0.000116	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARA—periodontitis	8.42e-05	0.000116	CbGpPWpGaD
Gefitinib—EGFR—Immune System—FGF2—periodontitis	8.41e-05	0.000116	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFB1—periodontitis	8.36e-05	0.000115	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	8.32e-05	0.000114	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—FGF2—periodontitis	8.13e-05	0.000112	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—periodontitis	8.1e-05	0.000111	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL8—periodontitis	8.05e-05	0.000111	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—periodontitis	8.03e-05	0.000111	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP9—periodontitis	8.01e-05	0.00011	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GGT1—periodontitis	7.96e-05	0.00011	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—periodontitis	7.91e-05	0.000109	CbGpPWpGaD
Gefitinib—EGFR—Disease—FGF2—periodontitis	7.76e-05	0.000107	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP9—periodontitis	7.73e-05	0.000106	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	7.58e-05	0.000104	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—periodontitis	7.42e-05	0.000102	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GGT1—periodontitis	7.26e-05	9.99e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL8—periodontitis	7.11e-05	9.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—periodontitis	7.09e-05	9.76e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—periodontitis	7.05e-05	9.71e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ACP5—periodontitis	7.04e-05	9.69e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—periodontitis	7e-05	9.63e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—periodontitis	6.85e-05	9.43e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	6.81e-05	9.37e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—periodontitis	6.61e-05	9.09e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GGT1—periodontitis	6.52e-05	8.97e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP9—periodontitis	6.43e-05	8.85e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—periodontitis	6.37e-05	8.76e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GGT1—periodontitis	6.36e-05	8.75e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—periodontitis	6.3e-05	8.67e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	6.21e-05	8.54e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—periodontitis	6.18e-05	8.5e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARA—periodontitis	6.03e-05	8.3e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—periodontitis	6.02e-05	8.29e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL2—periodontitis	6.01e-05	8.28e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GGT1—periodontitis	5.99e-05	8.25e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GGT1—periodontitis	5.94e-05	8.18e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARA—periodontitis	5.7e-05	7.84e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—periodontitis	5.47e-05	7.53e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—FGF2—periodontitis	5.44e-05	7.48e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—periodontitis	5.3e-05	7.29e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARA—periodontitis	5.19e-05	7.15e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—periodontitis	5.06e-05	6.97e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—periodontitis	4.98e-05	6.85e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—periodontitis	4.8e-05	6.6e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL8—periodontitis	4.75e-05	6.54e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARA—periodontitis	4.66e-05	6.42e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARA—periodontitis	4.55e-05	6.26e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—periodontitis	4.52e-05	6.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP9—periodontitis	4.3e-05	5.92e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARA—periodontitis	4.29e-05	5.9e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARA—periodontitis	4.25e-05	5.85e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—periodontitis	4.13e-05	5.69e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—periodontitis	3.99e-05	5.5e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—periodontitis	3.92e-05	5.4e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGT1—periodontitis	3.92e-05	5.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—periodontitis	3.81e-05	5.25e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—periodontitis	3.71e-05	5.1e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—periodontitis	3.54e-05	4.88e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—periodontitis	3.38e-05	4.65e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—periodontitis	3.03e-05	4.17e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—periodontitis	2.96e-05	4.07e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARA—periodontitis	2.8e-05	3.86e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—periodontitis	2.79e-05	3.84e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—periodontitis	2.76e-05	3.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—periodontitis	2.67e-05	3.68e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—periodontitis	1.82e-05	2.51e-05	CbGpPWpGaD
